Philong Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Philong Nguyen has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Joshua Wang
John Sealy School of Medicine, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555
9 shared publications - Yousef Tanas
Institute for Reconstructive Surgery, Houston Methodist Hospital, Weill Cornell Medicine, Houston, TX, USA
5 shared publications - Blancheneige Beohon
School of Medicine, John Sealy School of Medicine, University of Texas Medical Branch , 301 University Boulevard, Galveston, TX 77555-1317
3 shared publications - Joshua E. Lewis
John Sealy School of Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1317, USA
3 shared publications - Joshua Wang
Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch at Galveston, Galveston, USA
3 shared publications - Mbinui Ghogomu
School of Medicine, John Sealy School of Medicine, University of Texas Medical Branch , 301 University Boulevard, Galveston, TX 77555-1317
3 shared publications
Latest Publications
- 28 August 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
Vision Loss Following Nonsurgical Rhinoplasty Injections: Systematic Review of Cases and Management
Vision loss following nonsurgical rhinoplasty with dermal fillers is a rare but catastrophic complication. This systematic review synthesizes reported cases of visual impairment after nasal filler injection, focusing on mechanisms of injury, risk factors, management strategies, and outcomes. A systematic search of Scopus, Ovid Medline, and CINAHL was performed using terms related to visual changes, dermal fillers, and nonsurgical rhinoplasty. After duplicate removal, 1498 unique articles were screened using predefined inclusion and exclusion criteria. Data were extracted independently by 3 reviewers, and descriptive statistics summarized patient demographics, injection sites, filler types, treatments, and outcomes. Twenty-one articles met inclusion criteria, comprising 22 cases of vision loss. The mean patient age was 33.4 years, and 90.9% of patients were female. Hyaluronic acid was the most commonly used filler (50%). Vision loss occurred immediately after injection in 82% of cases. Injection site was reported for 18 patients (86%), with 5 patients (24%) receiving injections in multiple locations. The nasal bridge or dorsum was the most frequent injection site (12 patients, 57%), followed by the glabellar region (6 patients, 29%). Full visual recovery occurred in only 27% of cases, requiring an average of 5.3 months. Vision loss was often immediate and irreversible despite treatment with hyaluronidase, corticosteroids, and antibiotics. Hyperbaric oxygen therapy showed promise and warrants further study. Prevention through careful technique, detailed anatomical knowledge, and prompt intervention remains essential. Level of Evidence: 3 (Risk) For image description, please refer to the figure legend and surrounding text.
- 28 August 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
Vision Loss Following Nonsurgical Rhinoplasty Injections: Systematic Review of Cases and Management
Vision loss following nonsurgical rhinoplasty with dermal fillers is a rare but catastrophic complication. This systematic review synthesizes reported cases of visual impairment after nasal filler injection, focusing on mechanisms of injury, risk factors, management strategies, and outcomes. A systematic search of Scopus, Ovid Medline, and CINAHL was performed using terms related to visual changes, dermal fillers, and nonsurgical rhinoplasty. After duplicate removal, 1498 unique articles were screened using predefined inclusion and exclusion criteria. Data were extracted independently by 3 reviewers, and descriptive statistics summarized patient demographics, injection sites, filler types, treatments, and outcomes. Twenty-one articles met inclusion criteria, comprising 22 cases of vision loss. The mean patient age was 33.4 years, and 90.9% of patients were female. Hyaluronic acid was the most commonly used filler (50%). Vision loss occurred immediately after injection in 82% of cases. Injection site was reported for 18 patients (86%), with 5 patients (24%) receiving injections in multiple locations. The nasal bridge or dorsum was the most frequent injection site (12 patients, 57%), followed by the glabellar region (6 patients, 29%). Full visual recovery occurred in only 27% of cases, requiring an average of 5.3 months. Vision loss was often immediate and irreversible despite treatment with hyaluronidase, corticosteroids, and antibiotics. Hyperbaric oxygen therapy showed promise and warrants further study. Prevention through careful technique, detailed anatomical knowledge, and prompt intervention remains essential. Level of Evidence: 3 (Risk) For image description, please refer to the figure legend and surrounding text.
- Open Access
- 6 July 2026
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 36 (1) , 277
Preoperative ketorolac is associated with increased nonunion repair following femoral intramedullary nailing: a retrospective cohort study
Purpose: Nonsteroidal anti-inflammatory drugs (NSAIDs), including ketorolac, are widely used for perioperative analgesia, but their effects on bone healing remain debated. This study evaluates associations between preoperative intravenous ketorolac and outcomes on bone healing after femoral intramedullary nailing (IMN). Methods: Using the TriNetX database, we conducted a retrospective cohort analysis of adults undergoing femoral IMN who received a single preoperative IV ketorolac dose. Propensity score matching (1:1) produced 2 cohorts (n = 8,466 each). Outcomes included wound disruption, infection, sepsis, thromboembolism, mortality, readmission, and nonunion/malunion repair. Risk ratios, 95% confidence intervals, and P values were calculated ( P < 0.05). Results: Ketorolac was associated with increased wound disruption ( P = 0.034), and nonunion/malunion repair ( P = 0.015), but decreased mortality ( P = 0.014) and readmission ( P = 0.009). Conclusion: Preoperative ketorolac exposure was associated with higher rates of operative treatment of nonunion/malunion, although these findings should be interpreted cautiously because of substantial residual confounding and exposure misclassification. Level of evidence: Level III, Prognostic.
- 6 July 2026
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 36 (1) , 277
Open AccessPreoperative ketorolac is associated with increased nonunion repair following femoral intramedullary nailing: a retrospective cohort study
Purpose: Nonsteroidal anti-inflammatory drugs (NSAIDs), including ketorolac, are widely used for perioperative analgesia, but their effects on bone healing remain debated. This study evaluates associations between preoperative intravenous ketorolac and outcomes on bone healing after femoral intramedullary nailing (IMN). Methods: Using the TriNetX database, we conducted a retrospective cohort analysis of adults undergoing femoral IMN who received a single preoperative IV ketorolac dose. Propensity score matching (1:1) produced 2 cohorts (n = 8,466 each). Outcomes included wound disruption, infection, sepsis, thromboembolism, mortality, readmission, and nonunion/malunion repair. Risk ratios, 95% confidence intervals, and P values were calculated ( P < 0.05). Results: Ketorolac was associated with increased wound disruption ( P = 0.034), and nonunion/malunion repair ( P = 0.015), but decreased mortality ( P = 0.014) and readmission ( P = 0.009). Conclusion: Preoperative ketorolac exposure was associated with higher rates of operative treatment of nonunion/malunion, although these findings should be interpreted cautiously because of substantial residual confounding and exposure misclassification. Level of evidence: Level III, Prognostic.
- 1 June 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (9) , 1093-1096
Radiation‐Induced Skin Toxicity Risk in Breast Cancer Patients With Atopic or Allergic Conditions
Summary: Atopy increases both acute and long‐term radiation skin toxicity risk. Elevated dermatologic morbidity persists through 36 months post‐radiotherapy.
- 1 June 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (9) , 1093-1096
Radiation‐Induced Skin Toxicity Risk in Breast Cancer Patients With Atopic or Allergic Conditions
Summary: Atopy increases both acute and long‐term radiation skin toxicity risk. Elevated dermatologic morbidity persists through 36 months post‐radiotherapy.
- 1 June 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (12) , 2834-2841
Overweight and premorbid obesity status correlates with thromboembolism risk but not infection after total shoulder arthroplasty
- 1 June 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (12) , 2834-2841
Overweight and premorbid obesity status correlates with thromboembolism risk but not infection after total shoulder arthroplasty
- Open Access
- 31 May 2026
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (6) , rjag343
Septated gallbladder: a rare congenital anomaly and its clinical implications
A septated gallbladder (SG) is a rare anatomical variant characterized by the presence of one or more fibrous or muscular septa dividing the lumen into multiple chambers. While an acquired form of septation has been discussed, most reported cases are treated as congenital variants. This study presents a case of SG identified during clinical evaluation and discusses its clinical significance. The patient is a 64-year-old woman with a history of right upper quadrant (RUQ) abdominal pain that radiates to the right scapula. She reports pain beginning 10 years ago as intermittent episodes but has progressed over the past two months. Upon review of prior imaging studies, a SG was identified, and the patient was scheduled for a laparoscopic cholecystectomy. The presence of septa was confirmed intraoperatively. Following the procedure, her symptoms resolved completely. Awareness of SG is essential for clinicians and radiologists to prevent misdiagnosis and guide appropriate management. While incidental, symptomatic cases benefit from surgical intervention.
- 31 May 2026
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (6) , rjag343
Open AccessSeptated gallbladder: a rare congenital anomaly and its clinical implications
A septated gallbladder (SG) is a rare anatomical variant characterized by the presence of one or more fibrous or muscular septa dividing the lumen into multiple chambers. While an acquired form of septation has been discussed, most reported cases are treated as congenital variants. This study presents a case of SG identified during clinical evaluation and discusses its clinical significance. The patient is a 64-year-old woman with a history of right upper quadrant (RUQ) abdominal pain that radiates to the right scapula. She reports pain beginning 10 years ago as intermittent episodes but has progressed over the past two months. Upon review of prior imaging studies, a SG was identified, and the patient was scheduled for a laparoscopic cholecystectomy. The presence of septa was confirmed intraoperatively. Following the procedure, her symptoms resolved completely. Awareness of SG is essential for clinicians and radiologists to prevent misdiagnosis and guide appropriate management. While incidental, symptomatic cases benefit from surgical intervention.
- Open Access
- 12 February 2026
- Published by MDPI AG in European Burn Journal
- Vol. 7 (1) , 12
The Influence of BMI on Mortality and Clinical Outcomes After Burns
Background: Weight extremes are linked to morbidity, yet their impact on burn outcomes remains underinvestigated. Prior studies suggest an ‘obesity paradox’, showing survival benefits and better functional outcomes in obese patients. Methods: This study used the global real-world database TriNetX to assess the association between body mass index (BMI) and clinical outcomes in adult burn patients, categorized using WHO definitions. After 1:1 propensity score matching for demographics, burn severity, and smoke inhalation injury, clinical outcomes were analyzed over a six-month period following burn injury. Outcomes included mortality, sepsis, pneumonia, acute kidney injury (AKI), cardiovascular events, graft complications, skin infections, and psychological impairment. Results: After matching, 9736 patients were included in the underweight versus normal weight comparison, 72,274 in overweight versus normal weight, 71,195 in obesity versus normal weight, and 9732 in underweight versus obesity. Underweight patients were associated with higher mortality and increased risks of sepsis, pneumonia, cardiovascular events, and psychological impairment. Overweight and obese patients showed higher survival rates and overall better clinical outcome associations. Conclusions: These findings are consistent with the previously described ‘obesity paradox’ in burn care and identify underweight burn patients as a distinct high-risk subgroup.
- 12 February 2026
- Published by MDPI AG in European Burn Journal
- Vol. 7 (1) , 12
Open AccessThe Influence of BMI on Mortality and Clinical Outcomes After Burns
Background: Weight extremes are linked to morbidity, yet their impact on burn outcomes remains underinvestigated. Prior studies suggest an ‘obesity paradox’, showing survival benefits and better functional outcomes in obese patients. Methods: This study used the global real-world database TriNetX to assess the association between body mass index (BMI) and clinical outcomes in adult burn patients, categorized using WHO definitions. After 1:1 propensity score matching for demographics, burn severity, and smoke inhalation injury, clinical outcomes were analyzed over a six-month period following burn injury. Outcomes included mortality, sepsis, pneumonia, acute kidney injury (AKI), cardiovascular events, graft complications, skin infections, and psychological impairment. Results: After matching, 9736 patients were included in the underweight versus normal weight comparison, 72,274 in overweight versus normal weight, 71,195 in obesity versus normal weight, and 9732 in underweight versus obesity. Underweight patients were associated with higher mortality and increased risks of sepsis, pneumonia, cardiovascular events, and psychological impairment. Overweight and obese patients showed higher survival rates and overall better clinical outcome associations. Conclusions: These findings are consistent with the previously described ‘obesity paradox’ in burn care and identify underweight burn patients as a distinct high-risk subgroup.
- 4 February 2026
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 36 (1) , 98
Correction: Smoked nicotine dependence elevates risk of nonunion and revision surgery following bimalleolar ankle fracture ORIF: a propensity‑matched 90‑day and 2‑year TriNetX analysis
- 4 February 2026
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 36 (1) , 98
Correction: Smoked nicotine dependence elevates risk of nonunion and revision surgery following bimalleolar ankle fracture ORIF: a propensity‑matched 90‑day and 2‑year TriNetX analysis
- Open Access
- 14 January 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 8, ojag074
Vitamin D Deficiency as a Risk Factor for Hypertrophic Scarring and Reconstructive Surgeries After Burns
Background: Vitamin D plays an important role in immune regulation, collagen remodeling, and wound healing. In the general population, deficiency has been associated with poor wound repair and fibrosis, yet evidence in burn patients remains limited. Burn injuries often result in hypertrophic scarring and significant healthcare utilization for reconstructive and adjunctive procedures. Objectives: This study examines the impact of preexisting vitamin D deficiency on hypertrophic scarring and scar-related healthcare utilization in a large, multi-institutional cohort of burn patients. Methods: The TriNetX Research Network was queried for patients ≥18 years old with burn injuries between 2010 and 2023. Patients with vitamin D deficiency, defined as 25-hydroxyvitamin D <20 ng/mL within 1 month before injury, were matched 1:1 to nondeficient controls using propensity score matching. Matching variables included demographics, BMI, comorbidities, substance use, vitamin deficiencies (A, C, E, and K), calcidiol levels, and total burn surface area. The primary outcome was hypertrophic scarring. Secondary outcomes included scar-related interventions: Z-plasty and intralesional corticosteroid injections. Cumulative incidence was assessed at 3, 12, and 24 months. Hazard ratios (HRs) with 95% CIs were calculated using Cox proportional hazards models. Results: After matching, 6832 patients were included in each cohort. Vitamin D deficiency was associated with significantly higher rates of hypertrophic scarring at 3 months (5.82% vs 2.55%, HR 2.33, 95% CI, 1.93-2.81, P < .0001), 12 months (9.38% vs 4.56%, HR 2.12, 95% CI, 1.84-2.46, P < .0001), and 24 months (10.61% vs 5.26%, HR 2.09, 95% CI, 1.83-2.40, P < .0001). Vitamin D–deficient patients also demonstrated greater use of reconstructive procedures, including Z-plasty (HR 1.86-2.38) and corticosteroid injection (HR 3.14-3.56). Conclusions: Vitamin D deficiency is strongly associated with increased hypertrophic scarring and greater reliance on reconstructive and adjunctive procedures following burn injury. These results underscore the potential role of micronutrient status in long-term burn recovery. Prospective studies are needed to determine whether early detection and correction of deficiency can mitigate scarring and reduce healthcare utilization. Level of Evidence: 3 (Risk): For image description, please refer to the figure legend and surrounding text.
- 14 January 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal Open Forum
- Vol. 8, ojag074
Open AccessVitamin D Deficiency as a Risk Factor for Hypertrophic Scarring and Reconstructive Surgeries After Burns
Background: Vitamin D plays an important role in immune regulation, collagen remodeling, and wound healing. In the general population, deficiency has been associated with poor wound repair and fibrosis, yet evidence in burn patients remains limited. Burn injuries often result in hypertrophic scarring and significant healthcare utilization for reconstructive and adjunctive procedures. Objectives: This study examines the impact of preexisting vitamin D deficiency on hypertrophic scarring and scar-related healthcare utilization in a large, multi-institutional cohort of burn patients. Methods: The TriNetX Research Network was queried for patients ≥18 years old with burn injuries between 2010 and 2023. Patients with vitamin D deficiency, defined as 25-hydroxyvitamin D <20 ng/mL within 1 month before injury, were matched 1:1 to nondeficient controls using propensity score matching. Matching variables included demographics, BMI, comorbidities, substance use, vitamin deficiencies (A, C, E, and K), calcidiol levels, and total burn surface area. The primary outcome was hypertrophic scarring. Secondary outcomes included scar-related interventions: Z-plasty and intralesional corticosteroid injections. Cumulative incidence was assessed at 3, 12, and 24 months. Hazard ratios (HRs) with 95% CIs were calculated using Cox proportional hazards models. Results: After matching, 6832 patients were included in each cohort. Vitamin D deficiency was associated with significantly higher rates of hypertrophic scarring at 3 months (5.82% vs 2.55%, HR 2.33, 95% CI, 1.93-2.81, P < .0001), 12 months (9.38% vs 4.56%, HR 2.12, 95% CI, 1.84-2.46, P < .0001), and 24 months (10.61% vs 5.26%, HR 2.09, 95% CI, 1.83-2.40, P < .0001). Vitamin D–deficient patients also demonstrated greater use of reconstructive procedures, including Z-plasty (HR 1.86-2.38) and corticosteroid injection (HR 3.14-3.56). Conclusions: Vitamin D deficiency is strongly associated with increased hypertrophic scarring and greater reliance on reconstructive and adjunctive procedures following burn injury. These results underscore the potential role of micronutrient status in long-term burn recovery. Prospective studies are needed to determine whether early detection and correction of deficiency can mitigate scarring and reduce healthcare utilization. Level of Evidence: 3 (Risk): For image description, please refer to the figure legend and surrounding text.